Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic impact of (18)FDG-PET-CT findings in clinical stage III and IIB breast cancer.
Groheux D, Hindié E, Delord M, Giacchetti S, Hamy AS, de Bazelaire C, de Roquancourt A, Vercellino L, Toubert ME, Merlet P, Espié M. Groheux D, et al. Among authors: merlet p. J Natl Cancer Inst. 2012 Dec 19;104(24):1879-87. doi: 10.1093/jnci/djs451. Epub 2012 Dec 12. J Natl Cancer Inst. 2012. PMID: 23243198 Free PMC article.
Early assessment with 18F-fluorodeoxyglucose positron emission tomography/computed tomography can help predict the outcome of neoadjuvant chemotherapy in triple negative breast cancer.
Groheux D, Hindié E, Giacchetti S, Hamy AS, Berger F, Merlet P, de Roquancourt A, de Cremoux P, Marty M, Hatt M, Espié M. Groheux D, et al. Among authors: merlet p. Eur J Cancer. 2014 Jul;50(11):1864-71. doi: 10.1016/j.ejca.2014.04.020. Epub 2014 May 16. Eur J Cancer. 2014. PMID: 24841218
Breast infiltration by relapsed acute lymphoblastic leukaemia on FDG PET/CT.
Luzurier A, Van Der Gucht A, Blanc E, Lengline E, Groheux D, Vercellino L, Merlet P. Luzurier A, et al. Among authors: merlet p. Eur J Nucl Med Mol Imaging. 2015 Apr;42(5):811-2. doi: 10.1007/s00259-014-2977-2. Epub 2015 Jan 9. Eur J Nucl Med Mol Imaging. 2015. PMID: 25573633 No abstract available.
Baseline Tumor 18F-FDG Uptake and Modifications After 2 Cycles of Neoadjuvant Chemotherapy Are Prognostic of Outcome in ER+/HER2- Breast Cancer.
Groheux D, Sanna A, Majdoub M, de Cremoux P, Giacchetti S, Teixeira L, Espié M, Merlet P, de Roquancourt A, Visvikis D, Hatt M, Resche-Rigon M, Hindié E. Groheux D, et al. Among authors: merlet p. J Nucl Med. 2015 Jun;56(6):824-31. doi: 10.2967/jnumed.115.154138. Epub 2015 Apr 16. J Nucl Med. 2015. PMID: 25883123 Free article.
Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?
Groheux D, Majdoub M, Tixier F, Le Rest CC, Martineau A, Merlet P, Espié M, de Roquancourt A, Hindié E, Hatt M, Visvikis D. Groheux D, et al. Among authors: merlet p. Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1682-1691. doi: 10.1007/s00259-015-3110-x. Epub 2015 Jul 4. Eur J Nucl Med Mol Imaging. 2015. PMID: 26140849 Free PMC article.
¹⁸F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen.
Groheux D, Biard L, Giacchetti S, Teixeira L, Hindié E, Cuvier C, Vercellino L, Merlet P, de Roquancourt A, de Cremoux P, Resche-Rigon M, Espié M. Groheux D, et al. Among authors: merlet p. J Nucl Med. 2016 Apr;57(4):536-43. doi: 10.2967/jnumed.115.163907. Epub 2015 Dec 23. J Nucl Med. 2016. PMID: 26697967 Free article.
126 results